文献速递产科生殖医学

高BMI女性在IVF与非辅助单胎妊娠中的严重孕产妇发病率

Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies.
PubMed 文献 · Hum Reprod · 2018-01-01

基于加拿大安大略省114 409例单胎妊娠的队列研究显示,IVF妊娠的严重孕产妇发病率(SMM)升高(aRR 1.89,95%CI 1.06-3.39),高BMI(≥25 kg/m2)与SMM轻度相关(aRR 1.23,95%CI 1.04-1.45),两者无交互作用(P=0.22);高BMI与IVF对子痫前期和妊娠期糖尿病呈超相加效应。

要点

  • IVF妊娠SMM发生率为11.3/1000,高于非IVF妊娠,aRR 1.89(95%CI 1.06-3.39)。
  • 高BMI(≥25 kg/m2)与SMM轻度相关,aRR 1.23(95%CI 1.04-1.45)。
  • 高BMI与IVF对SMM无交互作用(P=0.22),但对子痫前期和妊娠期糖尿病呈超相加效应。

核心结论

  • SMM在IVF妊娠中更常见,在高BMI女性中也更常见,但未检测到两者对SMM的协同效应。
  • 高BMI与IVF对子痫前期和妊娠期糖尿病的风险呈超相加效应,对妊娠期高血压或剖宫产则未观察到。

研究设计与样本

  • 基于人群的队列研究,纳入2013年1月11日至2014年1月10日受孕的114 409例单胎妊娠,数据来自加拿大辅助生殖技术登记库(CARTR Plus)与安大略省出生登记库(BORN信息系统)的链接。
  • 纳入≥20周分娩的女性,排除<18岁或双胎妊娠;按受孕方式(IVF或非辅助)和孕前BMI(高BMI≥25 kg/m2或低-正常BMI<25 kg/m2)分类。
  • 主要结局为SMM(基于ICD-10编码的严重并发症复合指标);次要结局为妊娠期高血压、子痫前期、妊娠期糖尿病和剖宫产。
  • 采用对数二项回归估计校正风险比(aRR)及95%CI,校正因素包括母亲年龄、产次、教育、收入和基线母亲合并症。

主要发现

  • 114 409例妊娠中,1596例(1.4%)为IVF受孕;总体41.2%的样本为高BMI,IVF组与非IVF组相似。
  • 共观察到674例SMM事件(发生率5.9/1000次分娩)。
  • IVF与SMM风险升高相关(发生率11.3/1000;aRR 1.89,95%CI 1.06-3.39)。
  • 高BMI与SMM轻度相关(发生率7.0/1000;aRR 1.23,95%CI 1.04-1.45)。
  • 两因素间无交互作用(P=0.22);高BMI与IVF对子痫前期和妊娠期糖尿病呈超相加效应,对妊娠期高血压或剖宫产则未观察到。

临床怎么用

  • 作者认为,结果支持既往数据表明IVF妊娠和高BMI女性SMM风险更高,但这两个因素无交互作用。
  • 作者建议,寻求IVF治疗的超重和肥胖女性应接受妊娠风险咨询。
  • 作者认为,是否进行IVF的决定应基于临床判断,并考虑个体的成功机会和并发症风险。

局限性

  • 无法根据治疗原因评估结局。
  • II型错误(beta约25%)可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is there a synergistic risk of severe maternal morbidity (SMM) in overweight/obese women who conceived by IVF compared to normal-weight women without IVF? SUMMARY ANSWER: SMM was more common in IVF pregnancies, and among overweight/obese women, but we did not detect a synergistic effect of both factors. WHAT IS KNOWN ALREADY: While much is known about the impact of overweight and obesity on success rates after IVF, there is less data on maternal health outcomes. STUDY DESIGN, SIZE, DURATION: This is a population-based cohort study of 114 409 singleton pregnancies with conceptions dating from 11 January 2013 until 10 January 2014 in Ontario, Canada. The data source was the Canadian Assisted Reproductive Technologies Register (CARTR Plus) linked with the Ontario birth registry (BORN Information System). PARTICIPANTS/MATERIALS, SETTING, METHODS: We included women who delivered at ≥20 weeks gestation, and excluded those younger than 18 years or with twin pregnancies. Women were classified according to the mode of conception (IVF or unassisted) and according to pre-pregnancy BMI (high BMI (≥25 kg/m2) or low-normal BMI (<25 kg/m2)). The main outcome was SMM, a composite of serious complications using International Classification of Diseases, 10th revision (ICD-10) codes. Secondary outcomes were gestational hypertension, pre-eclampsia, gestational diabetes and cesarean delivery. Adjusted risk ratios (aRR) with 95% CI were estimated using log binomial regression, adjusted for maternal age, parity, education, income and baseline maternal comorbidity. MAIN RESULTS AND THE ROLE OF CHANCE: Of 114 409 pregnancies, 1596 (1.4%) were IVF conceptions. Overall, 41.2% of the sample had high BMI, which was similar in IVF and non-IVF groups. We observed 674 SMM events (rate: 5.9 per 1000 deliveries). IVF was associated with an increased risk of SMM (rate 11.3/1000; aRR 1.89, 95% CI: 1.06-3.39). High BMI was modestly associated with SMM (rate 7.0/1000; aRR 1.23, 95% CI: 1.04-1.45) There was no interaction between the two factors (P = 0.22). We noted supra-additive effects of high BMI and IVF on the risk of pre-eclampsia and gestational diabetes, but not gestational hypertension or cesarean delivery. LIMITATIONS, REASONS FOR CAUTION: We were unable to assess outcomes according to reason for treatment. Type II error (beta ~25%) may affect our results. WIDER IMPLICATIONS OF THE FINDINGS: Our results support previous data indicating a greater risk of SMM in IVF pregnancies, and among women with high BMI. However, these factors do not interact. Overweight and obese women who seek treatment with IVF should be counseled about pregnancy risks. The decision to proceed with IVF should be based on clinical judgment after considering an individual's chance of success and risk of complications. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Research Institute of the McGill University Health Centre (grant 6291) and also supported by the Trio Fertility (formerly Lifequest) Research Fund. The authors report no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Dayan N, Fell DB, Guo Y, et al. Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies. Hum Reprod. 2018. PMID: 29982477. doi:10.1093/humrep/dey224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。